XVIVO: Impressive organic growth - Redeye - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

XVIVO: Impressive organic growth - Redeye

{newsItem.title}

Redeye updates our outlook after Q2. XVIVO’s result indicated a mix of organisational improvements and strong demand. Again XVIVO beat both our and market expectations. We make a minor positive sales revision driven by a positive Disposable and Services revision together a slightly higher OPEX level reflecting investments in ongoing and approaching launches. We increase our base case to SEK 415 (405) with a Bull of SEK 800 and a Bear of SEK 105.

Länk till analysen i sin helhet: https://www.redeye.se/research/922153/xvivo-impressive-organic-growth?utm_source=finwire&utm_medium=RSS

Nyheter om Xvivo Perfusion

Läses av andra just nu

Om aktien Xvivo Perfusion

Senaste nytt